Hepatic resection for disappearing liver metastasis: a cost-utility analysis

The authors sought to estimate the cost–effectiveness of hepatic resection (HR) (strategy A) relative to surveillance plus 6 months of additional systemic chemotherapy (sCT) (strategy B) for patients with colorectal disappearing liver metastases (DLM). This study suggests that surveillance of DLM after sCT was more beneficial and cost–effective among patients >60 years with multiple factors predictive of true complete pathological response, such as normalization of CEA, HAI therapy, BMI ≤30 kg/m2, and diagnosis of DLM made through MRI.

Website: http://www.arjonline.org/medicine-and-health-care/american-research-journal-of-medicine-and-surgery/